2m 2m 2m 2m 2m 2m 2m
ADMA Biologics (ADMA)
NASDAQ
$9.28+$0.05 (+0.50%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.1BMarket Cap
- -42.71%1-Year Change
- BiotechnologyIndustry
ADMA Biologics (ADMA)
$9.28+$0.05 (+0.50%)
Earnings Score
Valuation | ADMA | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 0 | ||
Low Earnings Volatility | 4 |
Momentum Score
Valuation | ADMA | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 20.44% | ||
12-Month Momentum | -39.29% | ||
3-Month Risk Adjusted Momentum | 124.59% | ||
12-Month Risk Adjusted Momentum | -74.31% |
True Yield
Valuation | ADMA | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 8.00% | ||
Net Debt Paydown Yield | 0.008% |
Financial Health Score
Valuation | ADMA | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 9 |